Records containing: Human Papillomavirus Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-11-26HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs
-
CLINICAL_TRIALS study record update · 2019-11-21An Open-Label Phase III Clinical Trial to Study the Immunogenicity and Tolerability of GARDASIL®9 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Adult Women (27- to 45-Year-Olds) Compared to Young Adult Women (16 to 26 Year Olds)
-
CLINICAL_TRIALS study record update · 2019-10-09Integrating a Health Information Technology System With a Web-based Mobile Health Educational Intervention to Support More Effective Provider-patient Communication and HPV Vaccine Utilization
-
CLINICAL_TRIALS study record update · 2019-09-18Phase II Evaluation of Adjuvant Hyperfractionated Radiation and Docetaxel for HPV Associated Oropharynx Cancer
-
CLINICAL_TRIALS study record update · 2019-08-01Expanded Phase II Trial of a Carrageenan-Containing Gel for Prevention of HPV Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-06-20Oncologic and Obstetric Outcomes After Conization for Uterine Cervical Lesion: A Cohort Study
-
CLINICAL_TRIALS study record update · 2019-05-07The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases In Male and Female Aged Over 18 Years In China
-
CLINICAL_TRIALS study record update · 2019-04-10Phase IIa Study of the Efficacy of Single Agent BGJ398 (Infigratinib) in FGFR1-3 Translocated, Mutated, or Amplified Squamous Cell Carcinoma of the Head and Neck
-
CLINICAL_TRIALS study record update · 2019-01-23Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
-
CLINICAL_TRIALS study record update · 2018-08-09Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Clinics and the Community in Botswana
-
CLINICAL_TRIALS study record update · 2018-05-30A Double-blind, Placebo Controlled, Randomized, Phase IIa Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Repeated Topical Applications Over 42 Days of AP611074 5% Gel in Condyloma Patients
-
CLINICAL_TRIALS study record update · 2018-02-19HPV (Papilloma Human Virus) Vaccination in Young Women With Cystic Fibrosis and Followed in the Auvergne Rhône-Alpes Region
-
CLINICAL_TRIALS study record update · 2018-02-08Pilot Testing an HPV Self-Test Intervention: A Novel Strategy for Reducing Cervical Cancer in Appalachia
-
CLINICAL_TRIALS study record update · 2017-10-05A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand
-
CLINICAL_TRIALS study record update · 2017-07-02Prevalence of Human Papillomavirus in Men Living in the Northern Plains
-
CLINICAL_TRIALS study record update · 2017-01-06Clinical Evaluation of the APTIMA® HPV Assay on the TIGRIS® DTS® System in Women With ASC-US Pap Test Results and in Women 30 Years of Age or Older With Negative Pap Test Results Using ThinPrep Pap Test Specimens
-
CLINICAL_TRIALS study record update · 2016-09-13A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection
-
CLINICAL_TRIALS study record update · 2016-04-26A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of a 2-dose Regimen of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, Administered in Preadolescents and Adolescents (9 to 14 Year Olds) With a Comparison to Young Women (16 to 26 Year Olds)
-
CLINICAL_TRIALS study record update · 2015-11-26A Phase IIa Randomized, Double-Blind Controlled With Gardasil, Clinical Trial to Study theTolerability and Immunogenicity of V505 (a Multivalent Human Papilloma Virus [HPV] L1 Virus Like Particle [VLP] Vaccine) in Healthy 16 to 26 Year Old Women
-
CLINICAL_TRIALS study record update · 2015-08-11Prevalence and Type Distribution of Genital Human Papillomavirus (HPV) in Tanzanian Men
-
CLINICAL_TRIALS study record update · 2015-06-08The Impact of an Information-Motivation-Behavioral Skills (IMB) Based Educational Intervention to Improve Gardasil Use in a Population of Undergraduate Women
-
CLINICAL_TRIALS study record update · 2015-06-08A Randomized, Double-Blinded, Tolerability and Immunogenicity Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered Concomitantly With GARDASIL to 16- to 26- Year-Old Women
-
CLINICAL_TRIALS study record update · 2015-01-28The Human Papillomavirus (HPV) Transmission Pilot Study
-
CLINICAL_TRIALS study record update · 2015-01-13A Phase III Open-Label Clinical Trial to Study the Immunogenicity and Tolerability of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) Given Concomitantly With Menactra™ and Adacel™ in Preadolescents and Adolescents (11 to 15 Year Olds)
-
CLINICAL_TRIALS study record update · 2014-12-19A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26- Year-Old Women